Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05888441 · ClinicalTrials.gov registry record · NA
Obstacle Negotiation in Older People With and Without Vision Impairment
A NA study of Low Vision, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05888441: Recruiting NA study of Low Vision, sponsored by Indiana University.
NCT05888441 is a NA study of Low Vision that is actively recruiting participants, run by Indiana University. The registered enrollment target is 200 participants, below the 397-participant average among 8 other Low Vision trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05888441, a NA study of Low Vision, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to prevent falls in this population. The purpose of this study is to determine how adults with vision impairment change their gait behavior when stepping over obstacles that vary in height and contrast to the ground. We will then determine the mechanisms of gaze behavior that correlate to the gait behavior.
Primary Outcome
Distance from lowest point of foot (heel or toe) to top of obstacle
Conditions Studied
Interventions
- OTHER Obstacle characteristics
Study Locations (1)
Indiana
- Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT05888441 shows while recruiting
NCT05888441 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 397-participant average among 8 other Low Vision trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Low Vision appearing as the primary indexed condition, and to 1 intervention - of which Obstacle characteristics is the first listed.
NCT05888441 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05888441 about?
NCT05888441 is a clinical study titled "Obstacle Negotiation in Older People With and Without Vision Impairment". Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to preven...
What is the current status of trial NCT05888441?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-04-14. Estimated completion is 2028-12-31.
What conditions does trial NCT05888441 study?
This clinical trial studies the following conditions: Low Vision.
What interventions are being tested in trial NCT05888441?
The interventions under investigation include: Obstacle characteristics (OTHER).
Who is sponsoring clinical trial NCT05888441?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05888441 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Vision
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05888441's enrollment target sits among peer trials
200 3rd of 8 higher than 6 of 8 other Low Vision trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Vision trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision
RECRUITING · NA
-
Wearable Echolocation Aids Using Parametric Sound
RECRUITING · NA
-
SmartHMD for Improved Mobility
COMPLETED · NA
-
Community Access Through Remote Eyesight (CARE) Study
COMPLETED · NA
-
Socially Assistive Robots to Enhance Magnification Device Use for Reading
RECRUITING · Phase 1
-
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI